GlobeStar Therapeutics Corp (GSTC)
GlobeStar Therapeutics Corp (OTC: GSTC) is a healthcare company listed on OTC Markets as common stock. The company is described as a clinical-stage pharmaceutical business focused on patented drug formulations intended for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States. It is based in New York, New York. The company was previously known as AngioSoma, Inc. before adopting the GlobeStar Therapeutics Corporation name in July 2021.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-GSTC
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
1.241 K
|
